Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase

Neuroscience

Volumn 159, Issue 2, 2009, Pages 735-743

  Itoh, K ^a   Watanabe, M ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

generalized epilepsy model; ionotropic glutamate receptor knockout mice; kindling; nNOS inhibitors

Indexed keywords

1[2 (TRIFLUOROMETHYL)PHENYL]IMIDAZOLE; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; 3 BROMO 7 NITROINDAZOLE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; IMIDAZOLE DERIVATIVE; IONOTROPIC RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CONVULSION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; TONIC CLONIC SEIZURE;

ANIMALS; CONVULSANTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; IMIDAZOLES; INDAZOLES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PENTYLENETETRAZOLE; QUINOXALINES; SEIZURES;

EID: 60849118632     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.12.040     Document Type: Article

References (39)

1. Barañano D.E., Ferris C.D., and Snyder S.H. Atypical neural messengers. TRENDS in Neurosci 24 (2001) 99-106
2. Bashkatova V., Vitskova G., Narkevich V., Vanin A., Mikoyan V., and Rayevsky K. Nitric oxide content measured by ESR-spectroscopy in the rat brain is increased during pentylenetetrazole-induced seizures. J Mol Neurosci 14 (2000) 183-190
3. Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A 86 (1989) 9030-9033
4. Chapman A.G., Elwes R.D., Millan M.H., Polkey C.E., and Meldrum B.S. Role of glutamate and aspartate in epileptogenesis; contribution of microdialysis studies in animal and man. Epilepsy Res Suppl 12 (1996) 239-246
5. Chapman A.G. Glutamate receptors in epilepsy. Prog Brain Res 116 (1998) 371-383
6. Choi Y.B., Tenneti L., Le D.A., Ortiz J., Bai G., Chen H.S.V., and Lipton S.A. Molecular basis of NMDA receptor coupled ion channel modulation by S-nitrosylation. Nat Neurosci 3 (2000) 15-21
7. De Sarro G., Di Paola E.D., Gareri P., Gallelli L., Scotto G., and De Sarro A. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats. Eur J Pharmacol 368 (1999) 149-159
8. De Sarro G.B., Donato D.P., De Sarro A., and Vidal M.J. Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam Clin Pharmacol 5 (1991) 503-511
9. de Vasconcelos A.P., Gizard F., Marescaux C., and Nehlig A. Role of nitric oxide in pentylenetetrazol-induced seizures: age-dependent effects in the immature rat. Epilepsia 41 (2000) 363-371
10. During M.J., and Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341 (1993) 1607-1610
11. Endoh M., Maiese K., and Wagner J.A. Expression of the neural form of nitric oxide synthase by CA1 hippocampal neurons and other central nervous system neurons. Neuroscience 63 (1994) 679-689
12. Fisher R.S. Animal models of the epilepsies. Brain Res Rev 14 (1989) 245-278
13. Garthwaite J., and Boulton C.L. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57 (1995) 683-706
14. Garthwaite J., Garthwaite G., Palmer R.M., and Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 172 (1989) 413-416
15. Han D., Yamada K., Senzaki K., Xiong H., Nawa H., and Nabeshima T. Involvement of nitric oxide in pentylenetetrazole-induced kindling in rats. J Neurochem 74 (2000) 792-798
16. Hara S., Kuriiwa F., Iwata N., Mukai T., Kano S., and Endo T. Distinct effects of N omega-nitro-L-arginine on seizures induced by several drugs in mice. Pharmacol Biochem Behav 53 (1996) 673-677
17. Herberg L.J., Grottick A., and Rose I.C. Nitric oxide synthesis, epileptic seizures and kindling. Psychopharmacology 119 (1995) 115-123
18. Hevel J.M., and Marletta M.A. Nitric-oxide synthase assays. Methods Enzymol 233 (1994) 250-258
19. Itoh K., Watanabe M., Yoshikawa K., Kanaho Y., Berliner L.J., and Fujii H. Magnetic resonance and biochemical studies during pentylenetetrazole-kindling development: the relationship between nitric oxide, neuronal nitric oxide synthase and seizures. Neuroscience 129 (2004) 757-766
20. Kaneko K., Itoh K., Berliner L.J., Miyasaka K., and Fujii H. Consequences of nitric oxide generation in epileptic-seizure rodent models as studied by in vivo EPR. Magn Reson Med 48 (2002) 1051-1056
21. Kaputlu I., and Uzbay T. L-NNAME inhibits pentylenetetrazole and strychnine-induced seizures in mice. Brain Res 753 (1997) 98-101
22. -. Neuron 24 (1999) 461-469
23. Kiss J.P., and Vizi E.S. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. TRENDS in Neurosci 24 (2001) 211-215
24. Klatt P., Schmidt K., Lehner D., Glatter O., Bachinger H.P., and Mayer B. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J 14 (1995) 3687-3695
25. Lipton S.A. Prospects for clinically-tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci 16 (1993) 527-532
26. Loscher W., and Honack D. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37,849 and CGP 39,551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther 256 (1991) 432-440
27. Meldrum B.S., and Chapman A.G. Excitatory amino acid receptors and antiepileptic drug development. Adv Neurol 79 (1999) 965-978
28. Meldrum B.S. Excitatory amino acid transmitters in epilepsy. Epilepsia 32 Suppl 2 (1991) S1-S3
29. Micheva K.D., Buchanan J., Holz R.W., and Smith S.J. Retrograde regulation of synaptic vesicle endocytosis and recycling. Nat Neurosci 6 (2003) 925-932
30. Micheva K.D., Holz R.V., and Smith S.J. Regulation of presynaptic phosphatidylinositol 4,5-biphosphate by neuronal activity. J Cell Biol 154 (2001) 355-368
31. Namba T., Morimoto K., Sato K., Yamada N., and Kuroda S. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Brain Res 638 (1994) 36-44
32. Osonoe K., Mori N., Suzuki K., and Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res 663 (1994) 338-340
33. Panda K., Ghosh S., and Stuehr D.J. Calmodulin activates intersubunit electron transfer in the neuronal nitric-oxide synthase dimer. J Biol Chem 276 (2001) 23349-23356
34. Picot M.C., Baldy-Moulinier M., Daurès J.P., Dujols P., and Crespel A. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 49 (2008) 1230-1238
35. Przegaliñski E., Baran L., and Siwanowicz J. The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci Lett 217 (1996) 145-148
36. Ronne-Engström E., Hillered L., Flink R., Spännare B., Ungerstedt U., and Carlson H. Intracerebral microdialysis of extracellular amino acids in the human epileptic focus. J Cereb Blood Flow Metab 12 (1992) 873-876
37. Urbańska E.M., Drelewska E., Borowicz K.K., Błaszczak P., Kleinrok Z., and Czuczwar S.J. Ng-nitro-L-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice. J Neural Transm 103 (1996) 1145-1152
38. Xia Z., and Storm D.R. The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci 6 (2005) 267-276
39. Yamaguchi S., Donevan S.D., and Rogawski M.A. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52,466 and NBQX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res 15 (1993) 179-184